Publications

Journal Article Ppublish 25 citations
Electronic publication date
June 25, 2021

View on Pubmed.gov 34166514 | View on doi.org 10.1093/neuros/...

Intracranial Meningiomas Decrease in Volume on Magnetic Resonance Imaging After Discontinuing Progestin.

Search for publications in this journal Neurosurgery - 89(2):308-314

Abstract

BACKGROUND

The behavior of meningiomas under influence of progestin therapy remains unclear.

OBJECTIVE

To investigate the relationship between growth kinetics of intracranial meningiomas and usage of the progestin cyproterone acetate (PCA).

METHODS

This study prospectively followed 108 women with 262 intracranial meningiomas and documented PCA use. A per-meningioma analysis was conducted. Changes in meningioma volumes over time, and meningioma growth velocities, were measured on magnetic resonance imaging (MRI) after stopping PCA treatment.

RESULTS

Mean follow-up time was 30 (standard deviation [SD] 29) mo. Ten (4%) meningiomas were treated surgically at presentation. The other 252 meningiomas were followed after stopping PCA treatment. Overall, followed meningiomas decreased their volumes by 33% on average (SD 28%). A total of 188 (72%) meningiomas decreased, 51 (20%) meningiomas remained stable, and 13 (4%) increased in volume of which 3 (1%) were surgically treated because of radiological progression during follow-up after PCA withdrawal. In total, 239 of 262 (91%) meningiomas regressed or stabilized during follow-up. Subgroup analysis in 7 women with 19 meningiomas with follow-up before and after PCA withdrawal demonstrated that meningioma growth velocity changed statistically significantly (P = .02). Meningiomas grew (average velocity of 0.25 mm3/day) while patients were using PCA and shrank (average velocity of -0.54 mm3/day) after discontinuation of PCA.

CONCLUSION

Ninety-one percent of intracranial meningiomas in female patients with long-term PCA use decrease or stabilize on MRI after stopping PCA treatment. Meningioma growth kinetics change significantly from growth during PCA usage to shrinkage after PCA withdrawal.

References

No references provided.

Cited by 25 citations (total)

Journal Article

Management of cavernous sinus meningiomas: Consensus statement on behalf of the EANS skull base section.

Electronic publication date October 18, 2022

Search for publications in this journal Brain Spine

Marco V Corniola [...] Torstein R Meling et al.

Introduction

The evolution of cavernous sinus meningiomas (CSMs) might be unpredictable and the efficacy of their treatments is challenging due to...

Journal Article

Risk of intracranial meningioma with three potent progestogens: A population-based case-control study.

Electronic publication date August 9, 2022

Search for publications in this journal Eur J Neurol

Léa Hoisnard [...] Alain Weill et al.

BACKGROUND AND PURPOSE

A dose-dependent association between the use of cyproterone acetate (CPA) and intracranial meningioma has been identified but data...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Copyright

© Congress of Neurological Surgeons 2021.